BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35755983)

  • 1.
    Ahmadi N; Karimian A; Nasrabadi MN
    J Med Signals Sens; 2022; 12(2):171-175. PubMed ID: 35755983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorbed 18F-FDG dose to the fetus during early pregnancy.
    Zanotti-Fregonara P; Jan S; Taieb D; Cammilleri S; Trébossen R; Hindié E; Mundler O
    J Nucl Med; 2010 May; 51(5):803-5. PubMed ID: 20395321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of the beta+ dose to the embryo resulting from 18F-FDG administration during early pregnancy.
    Zanotti-Fregonara P; Champion C; Trébossen R; Maroy R; Devaux JY; Hindié E
    J Nucl Med; 2008 Apr; 49(4):679-82. PubMed ID: 18344434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal and maternal absorbed dose estimates for positron-emitting molecular imaging probes.
    Xie T; Zaidi H
    J Nucl Med; 2014 Sep; 55(9):1459-66. PubMed ID: 25024424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical voxel-based dosimetry through GATE Monte Carlo simulation using PET/CT imaging of mice.
    Gupta A; Lee MS; Kim JH; Park S; Park HS; Kim SE; Lee DS; Lee JS
    Phys Med Biol; 2019 Apr; 64(9):095007. PubMed ID: 30913544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Embryo/Fetus Doses from
    Işıkçı Nİ; Demir M
    J Med Phys; 2022; 47(1):109-113. PubMed ID: 35548038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetal Radiation Dose from 18F-FDG in Pregnant Patients Imaged with PET, PET/CT, and PET/MR.
    Zanotti-Fregonara P; Laforest R; Wallis JW
    J Nucl Med; 2015 Aug; 56(8):1218-22. PubMed ID: 26089550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of absorbed radiation doses to skin and S-values for organs at risk due to nasal administration of PET agents using Monte Carlo simulations.
    O'Doherty J; Mangini CD; Hamby DM; Boozer D; Singh N; Hippeläinen E
    Med Phys; 2021 Feb; 48(2):871-880. PubMed ID: 33330987
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Zanotti-Fregonara P; Ishiguro T; Yoshihara K; Ishii S; Enomoto T
    J Nucl Med; 2022 Oct; 63(10):1592-1597. PubMed ID: 35115366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation dose to the fetus from [(18)F]-FDG administration during the second trimester of pregnancy.
    Zanotti-Fregonara P; Koroscil TM; Mantil J; Satter M
    Health Phys; 2012 Feb; 102(2):217-9. PubMed ID: 22217594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined model-based and patient-specific dosimetry for
    Plyku D; Mena E; Rowe SP; Lodge MA; Szabo Z; Cho SY; Pomper MG; Sgouros G; Hobbs RF
    Eur J Nucl Med Mol Imaging; 2018 Jun; 45(6):989-998. PubMed ID: 29460025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimated Fetal Radiation Dose From 18 F-FDG PET/CT During the Second and Third Trimesters of Pregnancy.
    Al Mansour L; Tylski P; Chene G; Plaisant F; Janier M; Bolze PA; You B; Defez D; Tordo J; Flaus A
    Clin Nucl Med; 2024 Jul; 49(7):605-609. PubMed ID: 38778468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-Specific Computational Model and Dosimetry Calculations for PET/CT of a Patient Pregnant with Twins.
    Xie T; Zanotti-Fregonara P; Edet-Sanson A; Zaidi H
    J Nucl Med; 2018 Sep; 59(9):1451-1458. PubMed ID: 29371408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of absorbed dose for 2-[F-18]fluoro-2-deoxy-D-glucose using whole-body positron emission tomography and magnetic resonance imaging.
    Deloar HM; Fujiwara T; Shidahara M; Nakamura T; Watabe H; Narita Y; Itoh M; Miyake M; Watanuki S
    Eur J Nucl Med; 1998 Jun; 25(6):565-74. PubMed ID: 9618570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of fetal absorbed dose in V/Q scan in three trimesters of pregnancy using Monte Carlo simulation.
    Vakili S; Shahbazi-Gahrouei D; Pourasbaghi P; Raeisi E
    World J Nucl Med; 2021; 20(4):342-348. PubMed ID: 35018148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal Dose from PET and CT in Pregnant Patients.
    Burton CS; Frey K; Fahey F; Kaminski MS; Brown RKJ; Pohlen JM; Shulkin BL
    J Nucl Med; 2023 Feb; 64(2):312-319. PubMed ID: 36215573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of computational pregnant female and fetus models and assessment of radiation dose from positron-emitting tracers.
    Xie T; Zaidi H
    Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2290-2300. PubMed ID: 27349243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The safety of lymphatic mapping in pregnant breast cancer patients using Tc-99m sulfur colloid.
    Keleher A; Wendt R; Delpassand E; Stachowiak AM; Kuerer HM
    Breast J; 2004; 10(6):492-5. PubMed ID: 15569204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of GATE for bone and bone marrow with calculation specific absorbed fraction for photons.
    Ghaseminezhad SZ; Sadremomtaz A; Rajabi H
    J Cancer Res Ther; 2018; 14(3):647-650. PubMed ID: 29893333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal radiation dose in three common CT examinations during pregnancy - Monte Carlo study.
    Kelaranta A; Mäkelä T; Kaasalainen T; Kortesniemi M
    Phys Med; 2017 Nov; 43():199-206. PubMed ID: 28941740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.